Concepedia

Author

Mohamed Bouchahda

Hôpital Paul-BrousseORCID

Also Known As

Bouchahda Mohamed, Christian Focan, M Bouchahda, M. Bouchahda, Mohamed Bouchahda

78

Publications

1.2K

Citations

19

H-Index

32

Concepts

All Affiliations

Hôpital Paul-BrousseInsermAssistance Publique – Hôpitaux de ParisUniversity of WarwickBetsi Cadwaladr University Health Board
MB

About

Mohamed Bouchahda is an author at Hôpital Paul-Brousse specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

416

2

Health Sciences

2

2

23

3

Nursing

1

1

17

4

Public Health

1

1

17

5

Health Informatics

1

1

17

Mohamed Bouchahda

×

22

Publications

1.1K

Citations

17

H-Index

YearCitations

Hepatic Resection After Rescue Cetuximab Treatment for Colorectal Liver Metastases Previously Refractory to Conventional Systemic Therapy

René Adam, Thomas A. Aloia, Françis Lévi,

Journal of Clinical Oncology

2007

205

Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV

Françis Lévi, Valérie Boige, Mohamed Hebbar,

Annals of Oncology

2015

140

Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer

Abdoulaye Karaboué, T. Collon, Ida Pavese,

Cancers

2022

82

Circadian rest‐activity rhythm as an objective biomarker of patient‐reported outcomes in patients with advanced cancer

Pasquale F. Innominato, Sandra Komarzynski, Oxana Palesh,

Cancer Medicine

2018

74

Cetuximab efficacy and safety in a retrospective cohort of elderly patients with heavily pretreated metastatic colorectal cancer

Mohamed Bouchahda, Teresa Macarulla, J.P. Spano,

Critical Reviews in Oncology/Hematology

2008

69

Acquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosis

Mohamed Bouchahda, Abdoulaye Karaboué, Raphaël Saffroy,

Cancer Chemotherapy and Pharmacology

2010

64

Sex‐dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial

Pasquale F. Innominato, Annabelle Ballesta, Qi Huang,

Cancer Medicine

2020

63

Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer

Mohamed Bouchahda, René Adam, Sylvie Giacchetti,

Cancer

2009

57

Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability

Françis Lévi, Abdoulaye Karaboué, Lee Gorden,

Cancer Chemotherapy and Pharmacology

2010

46

Chronomodulated Irinotecan, Oxaliplatin, and Leucovorin-Modulated 5-Fluorouracil as Ambulatory Salvage Therapy in Patients with Irinotecan- and Oxaliplatin-Resistant Metastatic Colorectal Cancer

Dany Gholam, Sylvie Giacchetti, Catherine Brezault‐Bonnet,

The Oncologist

2006

36

Page 1